Julie Johnson
Julie Johnson (TX) sold $1K-$15K of $ABT (Abbott Laboratories Common Stock (ABT)) on May 12, 2026, part of 2 transactions in this filing.
HillSignal flagged 1 timing concern on this filing — trades that line up closely with related legislative or contract activity.
Price Movement Since Trade
How the largest positions have moved from the trade date to the most recent close.
Sign Up to See More
See the full trade breakdown, suspicious timing flags, and how this filing connects to active legislation.
Get Free Access →Suspicious Timing Detected
1 flagSystem: No suspicious timing patterns detected
These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
Connected Legislative Activity
4 signalsThese bills and contracts share tickers or sectors with this filing's trades.
H–1Bs for Physicians and the Healthcare Workforce Act
HR7961 exempts H-1B healthcare workers from a $100,000 fee and entry restriction, directly benefiting hospital operators and healthcare companies that rely on foreign talent. The bill is in early legislative stages but has 38 cosponsors, indicating bipartisan support. Key beneficiaries include HCA, UNH, JNJ, and ABT through reduced labor costs and improved staffing.
Wildlife Health Coordination and Zoonotic Disease Prevention Act of 2026
S. 4451 is an early-stage authorization bill for wildlife health coordination and zoonotic disease prevention. It authorizes no specific dollar amount and contains no mandatory spending, procurement mandates, or regulatory obligations. At this stage, it has negligible near-term market impact on healthcare, agricultural, or technology companies.
A bill to provide for the modernization of electronic case management systems, and for other purposes.
S4667 is an early-stage bill to modernize federal judiciary electronic case management systems. No funding amounts are specified. Impact on IT services contractors is marginal and probabilistic at this stage. CGI Federal is the one pure-play incumbent with demonstrated contract history.
Medical Device Electronic Labeling Act
The Medical Device Electronic Labeling Act (S.4519) in early Senate committee stage would let device manufacturers replace paper inserts with electronic labeling (paper on request). The bill authorizes no direct spending and is early-stage. Structural impact is slight cost reduction for large med-device companies like $MDT and $ABT but negligible to overall revenues.
Other Filings by Julie Johnson
Free — no credit card
Get the next Johnson trade the day it's disclosed
HillSignal tracks every Congressional stock filing and federal contract, scores its market impact with AI, and emails you the ones that matter — before they hit the news.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.